Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tenet Healthcare (THC) PT Raised to $170 at Mizuho
July 26, 2024 1:55 PM EDTMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank
July 25, 2024 5:06 AM EDTDeutsche Bank analyst Pito Chickering raised the price target on Tenet Healthcare (NYSE: THC) to $160.00 (from $155.00) while maintaining a Buy rating.
The analyst comments "Updated 2024 guidance of $3.9b EBITDA for 2024 and $3.975b at the high end is within spitting distance of consensus... More
Tenet Healthcare (THC) PT Raised to $171 at Citi
July 24, 2024 4:47 PM EDTCiti analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $171.00 (from $139.00) while maintaining a Buy rating.
The analyst comments "2Q24 EBITDA of $945M ($915 ex retro TX) was ahead of expectations, driven by strength in USPI rev/case, hospital volume... More
